Screener
Eligibility screening
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
14 US sites in FL, GA, IN, KY +7
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.